beta thalassemia

Search with Google Search with Bing
Information
Disease name
beta thalassemia
Disease ID
DOID:12241
Description
"A thalassemia characterized by the reduced or absent synthesis of the beta globin chains of hemoglobin." [url:http\://en.wikipedia.org/wiki/Beta_thalassemia, url:https\://ghr.nlm.nih.gov/condition/beta-thalassemia, url:https\://pubmed.ncbi.nlm.nih.gov/31030806/, url:https\://www.ncbi.nlm.nih.gov/books/NBK1426/, url:https\://www.ncbi.nlm.nih.gov/pubmed/10395635]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00408447 Active, not recruiting Phase 2 Stem Cell Transplant in Sickle Cell Disease and Thalassemia September 2004 February 2025
NCT00005934 Completed Phase 2 5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia June 2000 June 2003
NCT00159042 Completed Genetic Factors Affecting the Severity of Beta Thalassemia July 2004 July 1, 2017
NCT00790127 Completed Phase 1/Phase 2 Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia March 2009 May 2010
NCT01049854 Completed Phase 2 CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant September 2011 August 2018
NCT01931644 Completed At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions July 2013 April 2024
NCT02597595 Completed N/A Effects of Spirulina on Cardiac Functions in Children With Beta Thalassemia Major November 2014 October 2017
NCT00001958 Completed Phase 2 Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia) December 1999 February 2002
NCT04917978 Recruiting Association of Hb F Level With Clinical Severity of Beta Thalassemia December 1, 2019 December 30, 2025
NCT04929574 Recruiting Evaluation of Heart Status in Patients of Beta Thalassemia Using Echocardiogram July 1, 2021 December 30, 2025
NCT05357482 Recruiting Phase 1/Phase 2 Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia May 12, 2022 November 1, 2033
NCT06073860 Recruiting A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia November 2, 2023 September 27, 2029
NCT04918056 Unknown status Genetic Variants Affecting the Clinical Severity of Beta Thalassemia January 1, 2017 June 25, 2023
Disase is a (Disease Ontology)
DOID:10241
Cross Reference ID (Disease Ontology)
GARD:871
Cross Reference ID (Disease Ontology)
ICD10CM:D56.1
Cross Reference ID (Disease Ontology)
ICD9CM:282.44
Cross Reference ID (Disease Ontology)
MESH:D017086
Cross Reference ID (Disease Ontology)
MIM:613985
Cross Reference ID (Disease Ontology)
NCI:C34375
Cross Reference ID (Disease Ontology)
ORDO:848
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:65959000
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0005283